Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025 ...

Parts of the US can expect heavy snow falls and icy conditions as a severe winter storm moves eastwards from the southern plains. BBC Weather's Elizabeth Rizzini has the latest forecast and you ...

What is mild chronic small vessel disease ... with a 25% chance of strokes caused by the condition and 45% of dementia cases caused by CSVD. CSVD usually results from the narrowing or blockage ...

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

BERLIN--(BUSINESS WIRE)--Bayer today announced positive topline results of the Phase III study OASIS 4 investigating elinzanetant as non-hormonal treatment for moderate to severe vasomotor ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...

Could prove to be very beneficial to all involved with dementia care and reducing the stress levels of carers and people with dementia.' 'This project resonates with me, personal care in severe ...